| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.86M | - | |
| VP | 79.5K | $745.0K | - | |
| VP | 67.4K | $631.5K | - | |
| VP | 65.1K | $609.8K | - | |
| VP | 56.3K | $527.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $14.79 | $147,878.00 | -1.9% | |
| Apr 9, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $12.48 | $124,829.00 | -1.4% | |
| Apr 9, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $12.48 | $124,829.00 | -1.4% | |
| Mar 19, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $15.29 | $152,895.00 | -1.9% | |
| Mar 19, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $15.29 | $152,895.00 | -1.9% | |
| Mar 12, 2018 | Mirza Mansoor Raza79 | Director | Sale+OE | 2,500 | $17.01 | $42,525.00 | -100% | |
| Mar 7, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $16.15 | $161,463.00 | -1.4% | |
| Mar 7, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $16.15 | $161,463.00 | -1.4% | |
| Mar 5, 2018 | Mirza Mansoor Raza79 | Director | Sale+OE | 2,500 | $16.00 | $40,000.00 | -100% | |
| Mar 5, 2018 | Primiano Christopher Brett | EVP, Cbo, GC &Secretary | Sell | 2,500 | $16.03 | $40,076.00 | -33.9% |